News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Phase 1
Drug Development
BioPharm Executive: From the Bench to the Clinic
Alnylam’s victory with Patisiran in familial amyloid polyneuropathy (FAP) is significant for more than just the company and its patients.
October 14, 2017
·
1 min read
·
Karl Thiel
Drug Development
Biogen’s Alzheimer’s Pipeline Gets Some More Love
October 6, 2017
·
1 min read
Drug Development
Bay Area Acerta Pharma Falsified Early Data on a Cancer Compound, Now in Clinical Trials
October 6, 2017
·
2 min read
Drug Development
Amicus Rockets on Early-Stage Pompe Disease Data
October 4, 2017
·
2 min read
Drug Development
Top 5 Celgene Drugs With Blockbuster Potential
September 28, 2017
·
3 min read
Drug Development
Why Drugmakers Do Interim Clinical Trials
September 26, 2017
·
1 min read
Drug Development
3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon
September 22, 2017
·
3 min read
Drug Development
Down But Not Out: Juno Preps For Second Round Of CAR-T Cancer War
September 18, 2017
·
1 min read
Drug Development
Roche Slammed With Partial Holds for Two Combo Cancer Trials
September 18, 2017
·
3 min read
Drug Development
Secretive Moderna Shakes Up R&D Model, Shows Off Early-Stage Trial Data
September 14, 2017
·
4 min read
PRESS RELEASES
Press Releases
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
May 17, 2026
·
1 min read
Press Releases
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
May 17, 2026
·
9 min read
Press Releases
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
May 17, 2026
·
4 min read
Press Releases
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
May 15, 2026
·
13 min read
Press Releases
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101'
May 14, 2026
·
2 min read
Press Releases
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
May 14, 2026
·
7 min read
Press Releases
Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
May 14, 2026
·
3 min read
Press Releases
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
May 14, 2026
·
11 min read
Press Releases
MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
May 14, 2026
·
6 min read
Press Releases
Forward Therapeutics Announces Completion of Phase 1 Trials with Two Internally Discovered Next-Generation TNF Signaling Inhibitors Supporting Advancement to Phase 2 Clinical Development
May 14, 2026
·
3 min read
Press Releases
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
May 14, 2026
·
18 min read
Press Releases
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
May 14, 2026
·
5 min read
Press Releases
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
·
11 min read
Press Releases
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
May 14, 2026
·
10 min read
Press Releases
Encoded Therapeutics Presents New Clinical Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the ASGCT 2026 Presidential Symposium
May 13, 2026
·
6 min read
Press Releases
Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
May 13, 2026
·
2 min read
Press Releases
InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
May 13, 2026
·
4 min read
Press Releases
First-in-Class Oral PKM2 Modulator SYX-5219 Phase 1a Trial Data to be Presented at SID 2026
May 13, 2026
·
4 min read
Press Releases
Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
May 13, 2026
·
11 min read
Press Releases
HepaRegeniX to Present Interim Phase 1b Data for Darizmetinib (HRX215) in a Late-Breaking Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2026
May 13, 2026
·
4 min read
